Table 1.
Clinical and histological characteristics of NEC patient samples.
| n (%) | |
|---|---|
| Age at diagnosis (years) | |
| Mean | 56.6 |
| Standard deviation | 13.1 |
| Gender | |
| Male | 6 (54.5) |
| Female | 5 (45.5) |
| Site of disease | |
| Stomach | 3 (27.2) |
| Colorectum | 3 (27.2) |
| Pancreas | 5 (45.6) |
| Histological classification | |
| G3 NET | 6 (54.5) |
| G3 NEC | 5 (45.5) |
| FDG-PET/CT | |
| Positive | 8 (72.7) |
| Not done | 3 (27.3) |
| 68Ga-PET/CT octreoscan | |
| Positive | 4 (36.4) |
| Negative | 6 (54.5) |
| Not done | 1 (9.1) |
| Chemotherapy | |
| CDDP | 8 (72.7) |
| Carboplatin | 2 (18.1) |
| Other | 1 (9.2) |
| Best response to first-line chemotherapy | |
| PD | 3 (27.2) |
| SD | 3 (27.2) |
| PR | 5 (45.6) |
| Median overall survival, months [range] | 23 [6-70] |
NEC: neuroendocrine carcinoma; NET: neuroendocrine tumor; G: grade; FDG-PET/CT: fluorodeoxyglucose-positron emission tomography/computerized tomography; 68Ga: Gallium-68; CDDP: cisplatin; PD: progressive disease; SD: stable disease; PR: partial response.